Announcements Trials
Browse Landscape

Phase

Phase 2/3 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Wilms Tumor 2Prostatic Neoplasms 2Carcinoma, Non-Small-Cell Lung 2Breast Neoplasms 2Adenocarcinoma, Bronchiolo-Alveolar 2Adenocarcinoma of Lung 2Salivary Gland Neoplasms 1Rectal Neoplasms 1Lung Neoplasms 1Head and Neck Neoplasms 1Germinoma 1Extensive Stage Small Cell Lung Carcinoma 1Ependymoma 1Diabetes Insipidus 1Carcinoma, Intraductal, Noninfiltrating 1Carcinoma, Ductal, Breast 1Breast Carcinoma In Situ 1Anatomic Stage II Breast Cancer AJCC v8 1

Interventions

pembrolizumab 1epacadostat 1Radiotherapy, Intensity-Modulated 1Radiotherapy, Conformal 1Immunoglobulin G 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Extensive Stage Small Cell Lung Carcinoma × Radiotherapy, Conformal × 90 days × Clear all
NCT02635009 2026-05-19

Whole-Brain Radiation Therapy With or Without Hippocampal Avoidance in Limited Stage or Extensive Stage Small Cell Lung Cancer

NRG Oncology

Phase 2/3 Completed
418 enrolled 52 charts
Thoracic

Extensive Stage Small Cell Lung Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡